APA (7th ed.) Citation

Schmidt, I., Vergeer, R. A., Postma, M. R., van den Berg, G., Sterkenburg, A. J., Korsten-Meijer, A. G. W., . . . Kuijlen, J. M. A. (2025). Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: A non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]. European Journal of Nuclear Medicine & Molecular Imaging, 52(2), 660. https://doi.org/10.1007/s00259-024-06947-9

Chicago Style (17th ed.) Citation

Schmidt, I., et al. "Fluorescence Detection of Pituitary Neuroendocrine Tumour During Endoscopic Transsphenoidal Surgery Using Bevacizumab-800CW: A Non-randomised, Non-blinded, Single Centre Feasibility and Dose Finding Trial [DEPARTURE Trial]." European Journal of Nuclear Medicine & Molecular Imaging 52, no. 2 (2025): 660. https://doi.org/10.1007/s00259-024-06947-9.

MLA (9th ed.) Citation

Schmidt, I., et al. "Fluorescence Detection of Pituitary Neuroendocrine Tumour During Endoscopic Transsphenoidal Surgery Using Bevacizumab-800CW: A Non-randomised, Non-blinded, Single Centre Feasibility and Dose Finding Trial [DEPARTURE Trial]." European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 2, 2025, p. 660, https://doi.org/10.1007/s00259-024-06947-9.